A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function
Status:
Recruiting
Trial end date:
2024-07-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics and safety of a single dose of
JT001 in adult subjects with mild and moderate renal impairment compared to healthy
mean-matched subjects.The results of this study will guide the clinical recommendation
regarding whether or not a dose adjustment may be needed when treating patients with renal
impairment.